Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fukuda Denshi Co's EBIT per Share for the
three
months ended in Mar. 2026 was 円371.38.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円979.39.
During the past 12 months, the average EBIT per Share Growth Rate of Fukuda Denshi Co was 7.80% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 6.70% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 7.70% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 11.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Fukuda Denshi Co's EBIT per Share or its related term are showing as below:
TSE:6960'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -9.5 Med: 10.4 Max: 22.1
Current: 6.7
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Fukuda Denshi Co was 22.10% per year. The lowest was -9.50% per year. And the median was 10.40% per year.
TSE:6960's 3-Year EBIT Growth Rate is ranked worse than 52.92% of 686
companies
in the Medical Devices & Instruments industry
Industry Median: 9.25
vs TSE:6960: 6.70
Fukuda Denshi Co's EBIT for the
three
months ended in Mar. 2026 was 円10,211 Mil.
Fukuda Denshi Co (TSE:6960) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Fukuda Denshi Co EBIT per Share Related Terms
Fukuda Denshi Co EBIT per Share Historical Data
* Premium members only.
The historical data trend for Fukuda Denshi Co's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円979.39
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fukuda Denshi Co (TSE:6960) has a EBIT per Share of 円979.39 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Fukuda Denshi Co and its competitors. According to the industry distribution chart, Fukuda Denshi Co ranks #363 out of 686 companies in the Medical Devices & Instruments industry, placing it in the top 52.9%.
Is Fukuda Denshi Co's EBIT per Share too high?
Fukuda Denshi Co's current EBIT per Share is 円979.39. Based on the distribution chart, Fukuda Denshi Co ranks #363 out of 686 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Fukuda Denshi Co has a GF Score™ of 84/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fukuda Denshi Co's EBIT per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Fukuda Denshi Co ranks #363 out of 686 companies for EBIT per Share. This places Fukuda Denshi Co in the lower half of its industry. The industry median EBIT per Share is 9.25. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.25, based on 686 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Fukuda Denshi Co and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fukuda Denshi Co's current EBIT per Share is 円979.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fukuda Denshi Co stock overvalued right now?
Based on GuruFocus' analysis, Fukuda Denshi Co (TSE:6960) is currently considered Significantly Overvalued. The stock's GF Value™ is 円7,336.79, compared to a current price of 円11,250.00 — trading 53.3% above its estimated fair value. The current EBIT per Share is 円979.39. Fukuda Denshi Co's overall GF Score™ is 84/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Fukuda Denshi Co (TSE:6960), the current EBIT per Share is 円979.39 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fukuda Denshi Co (TSE:6960) Overvalued in 2026?
Based on GuruFocus' analysis, Fukuda Denshi Co stock appears to be overvalued.
The current stock price of 円11,250.00 is trading 53.3% above its estimated GF Value™ of 円7,336.79.
GuruFocus considers Fukuda Denshi Co to be Significantly Overvalued.
Key valuation signals for TSE:6960:
EBIT per Share: 円979.39
GF Value™: 円7,336.79 vs. price of 円11,250.00 (53.3% above fair value)
No single metric tells the full story. See the TSE:6960 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.
84GF Score
Get the complete analysis for TSE:6960
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6960 has been successfully added to your 
